INTRODUCTION: Cardiovascular diseases are the main cause of death in patients with type 1 diabetes mellitus (T1DM) and atherosclerotic process begins in childhood. OBJECTIVE: To evaluate lipid profile of patients with T1DM accompanied at the pediatric endocrinology (UEP), Hospital de Clínicas, Federal University of Paraná (HC-UFPR), the prevalence of dyslipidemia and its correlation with glycemic control, duration of T1DM, family history of dyslipidemia and nutritional profile status. METHODS: Data of diagnostic information, comorbidities, birth weight, sex, family history of diabetes, dyslipidemia and heart diseases were reviewed. Anthropometric measurements, glycemic control, blood pressure (BP), lipid profile, and pharmacological treatment for dyslipidemia were obtained in four moments: after three months of diagnosis (t1), two (t2), five (t3), and ten (t4) years of illness. RESULTS: 228 patients (122 girls), mean age at diagnosis of 7.3 years, were included. In t3 and t4 there was a significant increase in BP elevation. Prevalence of dyslipidemia was 31.7% in t1, 33.7% in t2; 37.4% in t3; and in 63.6% in t4. There was a significant increase in total cholesterol and LDL-cholesterol level over time (p<0.001) and a significant increase in triglycerides levels only in t4 (p=0.002). CONCLUSION: Changes in lipid profile in children and adolescents with T1DM are prevalent, but they are undertreated, and the greater age, the greater probability of developing dyslipidemia. Thus, screening for dyslipidemia should be done and pharmacological treatment should be encouraged as recommended.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.